Abstract
In any type of invasive surgery, the patient's individual risk of thromboembolism has to be weighed against the risk of bleeding. Based on various everyday situations in clinical routine, the purpose of the present expert recommendations is to provide appropriate perioperative and periinterventional management for patients with atrial fibrillation undergoing long-term treatment with the thrombin inhibitor dabigatran. As we currently have no routine laboratory test to measure therapeutic levels of the substance or the risk of bleeding, general measures such as a standardized documentation of the patient's history, a sufficient time interval between the last preoperative dose and the procedure, and careful control of local hemostasis should be given special attention.
References
May 25, 2002·Gastrointestinal Endoscopy·Glenn M EisenUNKNOWN American Society for Gastrointestinal Endoscopy
Oct 29, 2002·The Oncologist·Martin H CohenRichard Pazdur
Feb 25, 2005·Gastrointestinal Endoscopy·Marc J ZuckermanUNKNOWN Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy
Sep 4, 2007·Journal of Thrombosis and Haemostasis : JTH·B I ErikssonUNKNOWN RE-MODEL Study Group
Sep 18, 2007·Lancet·Bengt I ErikssonUNKNOWN RE-NOVATE Study Group
Nov 14, 2007·Circulation·Oussama M WazniAndrea Natale
Nov 28, 2007·Circulation·Samuel J Asirvatham
Apr 11, 2008·Clinical Pharmacokinetics·Joachim Stangier
May 13, 2008·Gut·A M VeitchUNKNOWN British Cardiovascular Intervention Society
Jul 24, 2008·Chest·James D DouketisJack Ansell
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Mar 11, 2010·Clinical Pharmacokinetics·Joachim StangierDago Mazur
Mar 31, 2010·Thrombosis and Haemostasis·Joanne van RynAndreas Clemens
Aug 31, 2010·European Heart Journal·UNKNOWN Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardDavid Taggart
Sep 23, 2010·Current Pharmaceutical Design·James D Douketis
Jan 5, 2011·Circulation·Rangadham NagarakantiStuart J Connolly
Feb 16, 2011·Circulation·L Samuel WannUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force
Feb 18, 2011·Journal of the American College of Cardiology·L Samuel WannCynthia M Tracy
Nov 25, 2011·The New England Journal of Medicine·Bryan A CottonJohn B Holcomb
Citations
Nov 13, 2013·Wiener klinische Wochenschrift·Dietmar FriesAnsgar Weltermann
Sep 5, 2013·Wiener medizinische Wochenschrift·Heinrich Wolfgang ThalerMarkus Gosch
Nov 10, 2013·Wiener medizinische Wochenschrift·Ernst J MüllerHeinrich W Thaler
Jul 13, 2013·Thrombosis and Haemostasis·R FerrandisL M Torres
May 16, 2014·Wiener klinische Wochenschrift·Ingrid Pabinger-FaschingReinhard Windhager
Nov 21, 2014·Wiener klinische Wochenschrift·Matthias HasunFranz Weidinger
Jul 13, 2013·Wiener klinische Wochenschrift·Hana Matejovska KubesovaJan Matejovsky
May 28, 2014·Seminars in Hematology·Sibylle A Kozek-Langenecker
Nov 2, 2012·Hämostaseologie·M SpannaglC Bode
Apr 20, 2016·Zeitschrift für Gerontologie und Geriatrie·Thomas J Luger, Markus F Luger
May 1, 2018·European Journal of Anaesthesiology·Stefan De HertFrank Wappler
May 14, 2017·Der Anaesthesist·Markus F Luger, Thomas J Luger